(Q36185056)

English

Serum and plasma determination of angiogenic and anti-angiogenic factors yield different results: the need for standardization in clinical practice

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Serum and plasma determination of angiogenic and anti-angiogenic factors yield different results: the need for standardization in clinical practice (English)

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

angiogenesis inhibitor

1 reference

based on heuristic

inferred from title

object named as

Edi Vaisbuch

7

0 references

object named as

Roberto Romero

2

0 references

Tinnakorn Chaiworapongsa

4

object named as

Tinnakorn Chaiworapongsa

1 reference

Europe PubMed Central

12 August 2017

PMC publication ID

Shali Mazaki-Tovi

8

object named as

Shali Mazaki-Tovi

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

10

object named as

Lami Yeo

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

6

object named as

Pooja Mittal

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

11

object named as

Sonia S Hassan

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Juan Pedro Kusanovic

3

object named as

Juan Pedro Kusanovic

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

author name string

Giovanna Oggè

1

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Zhong Dong

5

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Juan M Gonzalez

9

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

publication date

1 August 2010

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Journal of Maternal-Fetal and Neonatal Medicine

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

23

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

8

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

820-827

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3426311

1 October 2017

The change in concentrations of angiogenic and anti-angiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent development of preeclampsia and small-for-gestational age.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3426311

1 October 2017

Angiogenic factors for the prediction of pre-eclampsia in women with abnormal midtrimester uterine artery Doppler velocimetry

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3426311

1 October 2017

Circulatory soluble endoglin and its predictive value for preeclampsia in second-trimester pregnancies with abnormal uterine perfusion

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3426311

1 October 2017

A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a sma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3426311

1 October 2017

Prediction of preeclampsia - a workshop report

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3426311

1 October 2017

Second-trimester angiogenic factors as biomarkers for future-onset preeclampsia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3426311

1 October 2017

Identification of patients at risk for early onset and/or severe preeclampsia with the use of uterine artery Doppler velocimetry and placental growth factor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3426311

1 October 2017

Soluble endoglin contributes to the pathogenesis of preeclampsia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3426311

1 October 2017

An integrated model for the prediction of preeclampsia using maternal factors and uterine artery Doppler velocimetry in unselected low-risk women.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3426311

1 October 2017

A naturally occurring soluble form of vascular endothelial growth factor receptor 2 detected in mouse and human plasma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3426311

1 October 2017

Placental growth factor and its receptor, vascular endothelial growth factor receptor-1: novel targets for stimulation of ischemic tissue revascularization and inhibition of angiogenic and inflammatory disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3426311

1 October 2017

Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3426311

1 October 2017

Pitfalls in the measurement of circulating vascular endothelial growth factor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3426311

1 October 2017

Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3426311

1 October 2017

Platelet: transporter of vascular endothelial growth factor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3426311

1 October 2017

Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: significance for VEGF measurements and cancer biology.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3426311

1 October 2017

Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3426311

1 October 2017

Regulated expression on human macrophages of endoglin, an Arg-Gly-Asp-containing surface antigen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3426311

1 October 2017

Identification of distinct epitopes of endoglin, an RGD-containing glycoprotein of endothelial cells, leukemic cells, and syncytiotrophoblasts

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3426311

1 October 2017

Endoglin is a component of the transforming growth factor-beta receptor system in human endothelial cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3426311

1 October 2017

A longitudinal study of biochemical variables in women at risk of preeclampsia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3426311

2 July 2018

First-trimester prediction of hypertensive disorders in pregnancy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3426311

23 September 2018

Endoglin, PlGF and sFlt-1 as markers for predicting pre-eclampsia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3426311

23 September 2018

Effective prediction of preeclampsia by a combined ratio of angiogenesis-related factors.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3426311

23 September 2018

Soluble endoglin as a second-trimester marker for preeclampsia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3426311

23 September 2018

Sequential changes in antiangiogenic factors in early pregnancy and risk of developing preeclampsia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3426311

23 September 2018

Soluble endoglin and other circulating antiangiogenic factors in preeclampsia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3426311

23 September 2018

An elevated maternal plasma, but not amniotic fluid, soluble fms-like tyrosine kinase-1 (sFlt-1) at the time of mid-trimester genetic amniocentesis is a risk factor for preeclampsia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3426311

23 September 2018

Extra-placental expression of vascular endothelial growth factor receptor-1, (Flt-1) and soluble Flt-1 (sFlt-1), by peripheral blood mononuclear cells (PBMCs) in normotensive and preeclamptic pregnant women

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3426311

23 September 2018

Prediction of preeclampsia with maternal mid-trimester placental growth factor, activin A, fibronectin and uterine artery Doppler velocimetry

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3426311

23 September 2018

A national birth weight distribution curve according to gestational age in Chile from 1993 to 2000

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3426311

23 September 2018

Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia. Young Investigator Award

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3426311

23 September 2018

Prospective analysis of placenta growth factor (PlGF) concentrations in the plasma of women with normal pregnancy and pregnancies complicated by preeclampsia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3426311

23 September 2018

Circulating angiogenic factors and the risk of preeclampsia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3426311

23 September 2018

Longitudinal serum concentrations of placental growth factor: evidence for abnormal placental angiogenesis in pathologic pregnancies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3426311

23 September 2018

Erythroblasts are a source of angiogenic factors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3426311

23 September 2018

Vascular endothelial growth factor (VEGF) in breast cancer: comparison of plasma, serum, and tissue VEGF and microvessel density and effects of tamoxifen.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3426311

23 September 2018

Alternative splicing of vascular endothelial growth factor (VEGF)-R1 (FLT-1) pre-mRNA is important for the regulation of VEGF activity.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3426311

23 September 2018

Vascular endothelial growth factor (VEGF) is released from platelets during blood clotting: implications for measurement of circulating VEGF levels in clinical disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3426311

23 September 2018

First Trimester Placental Growth Factor and Soluble Fms-Like Tyrosine Kinase 1 and Risk for Preeclampsia

1 reference

https://api.crossref.org/works/10.3109%2F14767050903366119

21 January 2018

Elevated Serum Soluble Vascular Endothelial Growth Factor Receptor 1 (sVEGFR-1) Levels in Women with Preeclampsia

1 reference

https://api.crossref.org/works/10.3109%2F14767050903366119

21 January 2018

Soluble fms-Like Tyrosine Kinase 1 Is Increased in Preeclampsia But Not in Normotensive Pregnancies with Small-for-Gestational-Age Neonates: Relationship to Circulating Placental Growth Factor

1 reference

https://api.crossref.org/works/10.3109%2F14767050903366119

21 January 2018

Placental angiogenic growth factors and uterine artery Doppler findings for characterization of different subsets in preeclampsia and in isolated intrauterine growth restriction

1 reference

https://api.crossref.org/works/10.3109%2F14767050903366119

21 January 2018

Predictive value of angiogenic factors and uterine artery Doppler for early- versus late-onset pre-eclampsia and intrauterine growth restriction

1 reference

https://api.crossref.org/works/10.3109%2F14767050903366119

21 January 2018

ACOG technology assessment. Genetics and molecular diagnostic testing. Number 1, July 2002. American College of Obstetrics and Gynecology

1 reference

https://api.crossref.org/works/10.3109%2F14767050903366119

21 January 2018

Low maternal serum levels of placenta growth factor as an antecedent of clinical preeclampsia

1 reference

https://api.crossref.org/works/10.3109%2F14767050903366119

21 January 2018

Plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated prior to the clinical diagnosis of pre-eclampsia

2 references

https://api.crossref.org/works/10.3109%2F14767050903366119

21 January 2018

https://pubmed.ncbi.nlm.nih.gov/20158394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Second-trimester maternal serum placental growth factor and vascular endothelial growth factor for predicting severe, early-onset preeclampsia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20158394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Overexpression of the soluble vascular endothelial growth factor receptor in preeclamptic patients: pathophysiological consequences

1 reference

https://pubmed.ncbi.nlm.nih.gov/20158394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A Vascular Endothelial Growth Factor Antagonist Is Produced by the Human Placenta and Released into the Maternal Circulation1

1 reference

https://pubmed.ncbi.nlm.nih.gov/20158394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preeclampsia is associated with reduced serum levels of placenta growth factor

1 reference

https://pubmed.ncbi.nlm.nih.gov/20158394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vascular endothelial growth factor measured in platelet poor plasma allows optimal separation between cancer patients and volunteers: a key to study an angiogenic marker in vivo?

1 reference

https://pubmed.ncbi.nlm.nih.gov/20158394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Circulating concentrations of soluble endoglin (CD105) in fetal and maternal serum and in amniotic fluid in preeclampsia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20158394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Angiogenic factors for the prediction of preeclampsia in high-risk women

1 reference

https://pubmed.ncbi.nlm.nih.gov/20158394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Low maternal concentrations of soluble vascular endothelial growth factor receptor-2 in preeclampsia and small for gestational age

1 reference

https://pubmed.ncbi.nlm.nih.gov/20158394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Placental growth factor (PlGF) is a surrogate marker in preeclamptic hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/20158394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Maternal serum sFlt1 concentration is an early and reliable predictive marker of preeclampsia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20158394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Soluble vascular endothelial growth factor receptor-1 (sFlt-1) is increased throughout gestation in patients who have preeclampsia develop

1 reference

https://pubmed.ncbi.nlm.nih.gov/20158394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Endoglin is expressed on a subpopulation of immature erythroid cells of normal human bone marrow

1 reference

https://pubmed.ncbi.nlm.nih.gov/20158394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Localisation of placenta growth factor (PIGF) in human term placenta

1 reference

https://pubmed.ncbi.nlm.nih.gov/20158394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Suppression of serum vascular endothelial growth factor immunoreactivity in normal pregnancy and in pre-eclampsia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20158394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diagnostic utility of soluble fms-like tyrosine kinase 1 and soluble endoglin in hypertensive diseases of pregnancy

1 reference

https://pubmed.ncbi.nlm.nih.gov/20158394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

First-trimester serum levels of soluble endoglin and soluble fms-like tyrosine kinase-1 as first-trimester markers for late-onset preeclampsia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20158394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Maternal serum placental growth factor at 11 + 0 to 13 + 6 weeks of gestation in the prediction of pre-eclampsia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20158394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Selective deficit of angiogenic growth factors characterises pregnancies complicated by pre-eclampsia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20158394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evidence supporting that the excess of the sVEGFR-1 concentration in maternal plasma in preeclampsia has a uterine origin

1 reference

https://pubmed.ncbi.nlm.nih.gov/20158394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Circulating concentrations of sFlt1 (soluble fms-like tyrosine kinase 1) in fetal and maternal serum during pre-eclampsia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20158394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Screening test for preeclampsia through assessment of uteroplacental blood flow and biochemical markers of oxidative stress and endothelial dysfunction

1 reference

https://pubmed.ncbi.nlm.nih.gov/20158394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Maternal serum-soluble vascular endothelial growth factor receptor-1 in early pregnancy ending in preeclampsia or intrauterine growth retardation

1 reference

https://pubmed.ncbi.nlm.nih.gov/20158394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Circulating angiogenic factors in preeclampsia, gestational proteinuria, and preeclampsia superimposed on chronic glomerulonephritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20158394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of placenta growth factor and soluble Fms-like tyrosine kinase 1 receptor levels in mild and severe preeclampsia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20158394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Changes in circulating level of angiogenic factors from the first to second trimester as predictors of preeclampsia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20158394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predictive value of maternal angiogenic factors in second trimester pregnancies with abnormal uterine perfusion

1 reference

https://pubmed.ncbi.nlm.nih.gov/20158394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Alterations in placental growth factor levels before and after the onset of preeclampsia are more pronounced in women with early onset severe preeclampsia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20158394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Soluble vascular endothelial growth factor in various blood transfusion components

1 reference

https://pubmed.ncbi.nlm.nih.gov/20158394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy

1 reference

https://pubmed.ncbi.nlm.nih.gov/20158394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Placenta growth factor is induced in human keratinocytes during wound healing

1 reference

https://pubmed.ncbi.nlm.nih.gov/20158394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reductions of vascular endothelial growth factor and placental growth factor concentrations in severe preeclampsia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20158394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Placenta growth factor is not an early marker for the development of severe preeclampsia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20158394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Decreased maternal serum placenta growth factor in early second trimester and preeclampsia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20158394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasma placenta growth factor levels in midtrimester pregnancies

1 reference

https://pubmed.ncbi.nlm.nih.gov/20158394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Soluble VEGFR-1 secreted by endothelial cells and monocytes is present in human serum and plasma from healthy donors

1 reference

https://pubmed.ncbi.nlm.nih.gov/20158394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. American College of Obstetricians and Gynecologists

1 reference

https://pubmed.ncbi.nlm.nih.gov/20158394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.3109/14767050903366119

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36185056&oldid=1982984589"